Publication | Closed Access

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

Breast OncologyBreast Cancer PatientsMedicinePharmacologyPathologyTumour GradeBreast CancerCancer TreatmentComparative ValueOncologyTumor BiologyEndocrine-related Cancer